265 related articles for article (PubMed ID: 16440685)
41. Postrecurrence survival in patients with stage I non-small cell lung cancer.
Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
[TBL] [Abstract][Full Text] [Related]
42. [Surgical indication for non-small cell lung cancer with synchronous distant metastases].
Hirose M; Ota S; Ishibashi H
Kyobu Geka; 2006 Jan; 59(1):15-20. PubMed ID: 16440679
[TBL] [Abstract][Full Text] [Related]
43. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
44. [Surgical treatment of isolated adrenal metastasis from lung carcinoma].
Napolitano L; Mucilli F; Gargano E; Sacco R; Napolitano AM
G Chir; 2001; 22(6-7):243-6. PubMed ID: 11515463
[TBL] [Abstract][Full Text] [Related]
45. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
[TBL] [Abstract][Full Text] [Related]
47. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.
Congedo MT; Cesario A; Lococo F; De Waure C; Apolone G; Meacci E; Cavuto S; Granone P
J Thorac Cardiovasc Surg; 2012 Aug; 144(2):444-52. PubMed ID: 22713303
[TBL] [Abstract][Full Text] [Related]
48. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
49. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
50. [Detection of regional lymph node micrometastasis and its impact on long-term survival of non-small cell lung cancer (NSCLC) patients].
Ouyang WW; Lu B; Fu HY; He C; Long YG; Wang P
Ai Zheng; 2008 Jul; 27(7):756-60. PubMed ID: 18606072
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor.
Demir A; Gunluoglu MZ; Kara HV; Buyukpinarbasili N; Dincer SI
Thorac Cardiovasc Surg; 2008 Mar; 56(2):93-8. PubMed ID: 18278684
[TBL] [Abstract][Full Text] [Related]
52. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
54. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases.
Riquet M; Bagan P; Le Pimpec Barthes F; Banu E; Scotte F; Foucault C; Dujon A; Danel C
Ann Thorac Surg; 2007 Dec; 84(6):1818-24. PubMed ID: 18036891
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
56. Pooled analysis for surgical treatment for isolated adrenal metastasis and non-small cell lung cancer.
Gao XL; Zhang KW; Tang MB; Zhang KJ; Fang LN; Liu W
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):1-7. PubMed ID: 27664424
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.
Tanvetyanon T; Robinson LA; Schell MJ; Strong VE; Kapoor R; Coit DG; Bepler G
J Clin Oncol; 2008 Mar; 26(7):1142-7. PubMed ID: 18309950
[TBL] [Abstract][Full Text] [Related]
59. [Kidney cancer metastasis to the adrenal gland. Role of adrenalectomy].
Matveev VB; Baronin AA
Urologiia; 2002; (3):11-5. PubMed ID: 12180050
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of surgical treatment of primary lung cancer having M1 diseases].
Tabata T; Kondo T
Kyobu Geka; 2006 Jan; 59(1):11-4. PubMed ID: 16440678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
